BY ANJA HAUGE
-
Majority of ALK’s China workforce secures new roles with partner
The companion concerned is Gensci, with whom ALK participated in a collaboration in the 3rd quarter.
-
CFO rejects notion that collapsed takeover has had consequences for Bavarian Nordic
Recently, an attempted requisition of Bavarian Nordic was deserted. The significant occasions have actually been slammed by a number of celebrations, however the CFO sees no consid…
-
Private equity funds after failed attempt to acquire Bavarian: “We made an attractive offer”
Nordic Resources and Permira remain to think that their quote for Bavarian Nordic shown Bavarian Nordic’s possibility.
-
Private equity funds’ takeover bid for Bavarian falls through: Only 60% support
Both personal equity funds have actually not prospered in taking control of Bavarian Nordic. ( To be upgraded)
-
Obesity drug candidate Cagrilintid begins late-stage program at Novo Nordisk
Today, November 5, Novo Nordisk will certainly launch 2 stage 3 researches, called Renew.
-
Novo Nordisk obesity candidate moves on to new trial
The medication prospect “three-way” is currently being sent out on to a stage Ib/II research study.
-
Analyst on Novo’s bid for Metsera: “An expression of desperation to add new products to the pipeline”
The marketplace is presently checking out the information adversely, states a Jyske Financial institution expert. Nonetheless, Novo Nordisk’s proposal for Metsera might likew…
-
Analyst on Novo’s bid for Metsera: “An expression of desperation to add new products to the pipeline”
The market is currently viewing the news negatively, says a Jyske Bank analyst. However, Novo Nordisk’s bid for Metsera could also be seen as a wise move, he says.
-
Bavarian Nordic ramps up in the US to deal with declining typhoid market
The vaccination firm will certainly currently transform the trend by employing a sales pressure concentrated on typhoid in the United States.
-
Abacus completes first pharma acquisition with new strategic focus
The precise dimension of the purchase stays vague.
